Please login to the form below
prescription drugs
This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.
Purdue to pay over $8bn to settle opioid-related criminal claims
Filings made by 49 states in the US allege that Purdue pushed prescription painkillers on doctors and patients while knowingly minimising the harmful side effects of the drugs. ... Purdue manufactured the prescription opioid painkiller OxyContin, which
Latest news
-
Lilly joins new Medicare scheme to reduce insulin prices
That includes recent draft guidance published by the Trump administration which would allow states in the US to import prescription drugs from Canada to try to reduce cost, although that plan ... excludes biologics such as insulin as well as intravenous
-
AbbVie/Allergan merger faces renewed public opposition despite divestments
AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and ... prevents “rival
-
Lilly extends range of cut-price insulins in the US
list price of the branded drugs – will be available in April, according to the company. ... Last month, the Trump administration published draft guidance which would allow states in the US to import prescription drugs from Canada to try to reduce
-
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US
range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
-
The year in review
And earlier this year, court documents revealed that Amazon may seriously be considering working directly with health plans and employers to sell prescription drugs – a move that would effectively allow it
More from news
Approximately 2 fully matching, plus 179 partially matching documents found.
Latest Intelligence
-
Eliminating pharmaceutical rebates, is this déjà vu?
Due to consolidation in the industry, most prescription drug benefits, including Medicare Part D benefits, are administered by several significant PBMs. ... It also provides more transparency to patients and other stakeholders about the actual costs of
-
BRIC markets
prescription drugs is a problem,” he continued. ... Drugs that aren’t listed may maintain a higher price and the lack of access may not necessarily be a negative for them.”.
-
Drug launches to watch in 2019
11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... Now there is a growing need for treatments which can
-
Behaviour change – a missing ingredient?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
US health reforms
In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs
More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest appointments
-
Keith Webber leaves FDA for Perrigo
Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs. ... This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.
-
Genzyme’s Richard Moscicki joins FDA
prescription-only drugs available in the US.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Behaviour change – is there something missing?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
How to build an online medical information service that resonates with your customers
However, as an increasing number of drugs have come off patent, there is a growing need for clinical and scientific medical information.Now more and more pharmaceutical companies are investing in ... Manufacturers are responsible for the way they respond
-
PEGASUS JOINS ASHFIELD HEALTHCARE COMMUNICATIONS
Sharp is also a world leader in ’Track and Trace’ serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability. .
-
How to design patient services with social media within the ABPI code guidelines
When designing digital services and informational materials for prescription drugs or services, there are unique considerations that must be taken around how that information is accessed and used. ... The code explains how use of social media to discuss
-
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
drugs, whilst boosting generic drug prescription and supporting the domestic drug industry. ... Following the Act, any drug registered as a “similares” have to meet the same bioequivalence standards as generic drugs.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Communique - Communiqué Awards
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Windrose Consulting Group
Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
